Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

(2021) Dominick J. Angiolillo et al.   CIRCULATION

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2020) Jean-Philippe Collet et al.   EUROPEAN HEART JOURNAL

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention

(2015) Philippe Généreux et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates

(2015) Marco Valgimigli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET